Sort
16,300 grants matching “fatty liver disease”
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2020 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2018 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2021 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2022 · DK
Nuclear receptors and their Coactivators as Mediators of Systems Metabolism
$1,505,750Bert W O'Malley · Baylor College Of Medicine · P01 · FY2019 · DK
Interventions Testing Program at UM
$1,502,332Richard A. Miller · University Of Michigan At Ann Arbor · U01 · FY2025 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,501,317Rima F Kaddurah-Daouk · Duke University · U01 · FY2019 · AG
Building Access to Food through Systems and Solidarity
$1,500,028Stella S Yi · New York University School Of Medicine · R01 · FY2024 · MD
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,500,000Steven E Shoelson · Joslin Diabetes Center · U01 · FY2010 · DK
Genetic Control of Metabolic Flux in Response to Diet
$1,500,000Alan D Attie · University Of Wisconsin-Madison · RC2 · FY2022 · DK
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center for VEDS
$1,500,000James A Tonascia · Johns Hopkins University · U24 · FY2022 · DK
Genetic Control of Metabolic Flux in Response to Diet
$1,500,000Alan D Attie · University Of Wisconsin-Madison · RC2 · FY2023 · DK
Genetic Control of Metabolic Flux in Response to Diet
$1,499,999Alan D Attie · University Of Wisconsin-Madison · RC2 · FY2021 · DK
VEDS Year2-Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,499,998James A Tonascia · Johns Hopkins University · U24 · FY2023 · DK
Intestinal bacterial metagenome in pediatric NAFLD
$1,499,969Nita H Salzman · Medical College Of Wisconsin · R01 · FY2012 · DK
Botanicals and Metabolic Syndrome
$1,499,737Lsu Pennington Biomedical Research Ctr · P50 · FY2005 · AT
AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)
$1,499,427Neil B Ruderman · Boston Medical Center · P01 · FY2012 · HL
IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE.
$1,499,276Valerie Humblet · Collagen Medical, Llc · N43 · FY2015 · HL
SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT
$1,496,733Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Botanicals and Metabolic Syndrome
$1,494,741William T. Cefalu · Lsu Pennington Biomedical Research Ctr · P50 · FY2006 · AT
HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY
$1,493,500Cecilia M Shikuma · University Of Hawaii At Manoa · UG3 · FY2023 · MD
Clinical Research Network in Non-Alcoholic Steatohepati*
$1,489,129Johns Hopkins University · U01 · FY2004 · DK
Regulation of Liver by Nuclear Ca2+ Signaling
$1,485,066Michael H Nathanson · Yale University · P01 · FY2011 · DK
Human on a chip systems to investigate disease comorbidities common in the aged population
$1,483,966Michael L Shuler · Hesperos, Llc · R44 · FY2022 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population
$1,483,966Michael L Shuler · Hesperos, Llc · R44 · FY2021 · AG